Immunology and Microbiology
Beta Interferon
100%
Interferon Type I
83%
Coxsackievirus B3
83%
Time
66%
Viral Load
33%
Myocarditis
33%
Animal
33%
Antiserum
16%
CD-1 Mouse
16%
Heart Tissue
16%
Viral Entry
16%
Skin Fibroblast
16%
Primary Culture
16%
Mouse
16%
Reduction (Chemistry)
16%
Pharmacology, Toxicology and Pharmaceutical Science
Beta Interferon
100%
Interferon
83%
Virus
83%
Coxsackievirus B3
83%
Polyinosinic Polycytidylic Acid
33%
Myocarditis
33%
Animal
33%
Antiserum
16%
Antivirus Agent
16%
Mouse
16%
CD-1 Mouse
16%
Heart Muscle Injury
16%
Absence
16%
Medicine and Dentistry
Beta Interferon
100%
Interferon
83%
Coxsackievirus B3
83%
Myocarditis
33%
Primary Culture
33%
Polyinosinic Polycytidylic Acid
33%
Lesion
16%
In Vitro
16%
Antiserum
16%
Skin Fibroblast
16%
Antivirus Agent
16%
Heart Muscle Injury
16%
Heart Tissue
16%
Virus Entry
16%
Culture
16%
Absence
16%
Biochemistry, Genetics and Molecular Biology
Interferon
83%
Coxsackievirus B3
83%
Time
66%
Inoculation
50%
Virus
50%
Animal
33%
Virus Load
33%
CD-1 Mouse
16%
Virus Entry
16%
Mouse
16%
Reduction (Chemistry)
16%
In Vitro Study
16%